Cargando…

Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease

Detalles Bibliográficos
Autor principal:	Jo, Sang-Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715159/ https://www.ncbi.nlm.nih.gov/pubmed/26889413 http://dx.doi.org/10.1016/j.krcp.2012.04.324

Ejemplares similares

The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy
por: Cho, Eunjung, et al.
Publicado: (2022)

Radiocontrast Media: Applications and Concerns
por: Mahajan, Rajiv, et al.
Publicado: (2019)

Role of Reactive Oxygen Species in Pathogenesis of Radiocontrast-Induced Nephropathy
por: Pisani, Antonio, et al.
Publicado: (2013)

Resin from Virola oleifera Protects Against Radiocontrast-Induced Nephropathy in Mice
por: Bôa, Igor Santos Fonte, et al.
Publicado: (2015)

The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy
por: Kim, Ji Eun, et al.
Publicado: (2019)

A new update for radiocontrast-induced nephropathy aggravated with glycerol in rats: the protective potential of epigallocatechin-3-gallate
por: Palabiyik, Saziye Sezin, et al.
Publicado: (2017)

Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT
por: Choi, Heejung, et al.
Publicado: (2012)

Radiocontrast Media Hypersensitivity Reactions in Children
por: Saretta, Francesca, et al.
Publicado: (2022)

Incomplete Recovery from the Radiocontrast-Induced Dysregulated Cell Cycle, Adhesion, and Fibrogenesis in Renal Tubular Cells after Radiocontrast (Iohexol) Removal
por: Chen, Hsing-Yu, et al.
Publicado: (2023)

The efficacy of single premedication with antihistamines for radiocontrast media hypersensitivity
por: Lee, So-Hee, et al.
Publicado: (2016)

Intraductal Ultrasonography without Radiocontrast Cholangiogram in Patients with Extrahepatic Biliary Disease
por: Lim, Sung-Uk, et al.
Publicado: (2015)

Electronic Consultation Support System for Radiocontrast Media Hypersensitivity Changes Clinicians' Behavior
por: Yang, Min-Suk, et al.
Publicado: (2018)

Radiocontrast media hypersensitivity in the Asia Pacific region
por: Lee, Suh-Young, et al.
Publicado: (2014)

Successful Desensitization to the Radiocontrast Material Iohexol (Omnipaque™)
por: Saad, Abeer, et al.
Publicado: (2022)

Impact of Mannose-Binding Lectin Deficiency on Radiocontrast-Induced Renal Dysfunction
por: Osthoff, Michael, et al.
Publicado: (2013)

Clearance and Safety of the Radiocontrast Medium Iopamidol in Peritoneal Dialysis Patients
por: Hatakeyama, Shingo, et al.
Publicado: (2011)

Management of chronic liver diseases and cirrhosis: current status and future directions
por: Xu, Jing-Hang, et al.
Publicado: (2020)

Direct coronary stenting in reducing radiation and radiocontrast consumption
por: Caluk, Jasmin, et al.
Publicado: (2010)

Systemic and renal hemodynamic effects of intra-arterial radiocontrast
por: Calzavacca, Paolo, et al.
Publicado: (2014)

Successful desensitization to radiocontrast media in two high-risk cardiac patients
por: Al-Ahmad, Mona, et al.
Publicado: (2017)

Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media
por: Michael, Ashour, et al.
Publicado: (2014)

Acute Onset of Bullous Skin Rash and Acute Kidney Injury after Exposure to Radiocontrast: Sweet’s Syndrome
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023)

Chronic Kidney Disease in Patients with Chronic Liver Disease: What Is the Price Tag?
por: Wong, Robert J., et al.
Publicado: (2020)

Radiocontrast Agent Diatrizoic Acid Induces Mitophagy and Oxidative Stress via Calcium Dysregulation
por: Ward, Dakota B., et al.
Publicado: (2019)

Does Orally-Administered Radiocontrast Impair Ultrasound Image Quality in Pediatric Patients?
por: Patel, Amit, et al.
Publicado: (2020)

NASH‐related cirrhosis: An occult liver disease burden
por: Arrese, Marco, et al.
Publicado: (2017)

Effectiveness of premedication for hypersensitivity reactions to radiocontrast media in one tertiary hospital
por: Jung, JaeWoo, et al.
Publicado: (2014)

Imaging articular cartilage in osteoarthritis using targeted peptide radiocontrast agents
por: Fowkes, Milan M., et al.
Publicado: (2022)

The simpler, the better: culprit-only intervention is beneficial in patients with chronic kidney disease with concurrent acute myocardial infarction and multivessel disease
por: Jo, Sang-Ho
Publicado: (2015)

MON-059 Acute Hyponatremia Following Computed Tomography Radiocontrast in a Pediatric Patient
por: Chiu, Harvey Kenn, et al.
Publicado: (2020)

Diagnostic and Prognostic Markers in Liver Cirrhosis
por: Augustin, Salvador, et al.
Publicado: (2011)

Prognostic Assessment and Management of Liver Cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2017)

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis
por: Kwo, Paul, et al.
Publicado: (2020)

Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease
por: Kroneberger, Christian, et al.
Publicado: (2015)

Systemic hypersensitivity reaction to Omnipaque radiocontrast medium: a case of mini‐DRESS
por: George, Christina, et al.
Publicado: (2016)

Case of Cirrhosis of Liver and Kidneys
por: Smolt, C. F.
Publicado: (1878)

Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis
por: Lee, Chang Hun, et al.
Publicado: (2021)

A need for patient-centered care in managing patients with liver cirrhosis
por: Yoon, Eileen L.
Publicado: (2021)

Regression of liver cirrhosis: Orthodoxy or paradigm shift?
por: Yu, Su Jong
Publicado: (2015)

Critical issues in the diagnosis and treatment of liver cirrhosis
por: Wang, Xing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9u54efmbu3fi7h6fq8pgcojadt